UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 83 filers reported holding UROGEN PHARMA LTD in Q2 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,121 | -95.5% | 80 | -94.7% | 0.00% | -100.0% |
| Q3 2021 | $25,000 | +733.3% | 1,509 | +707.0% | 0.00% | – |
| Q2 2021 | $3,000 | +50.0% | 187 | +46.1% | 0.00% | – |
| Q1 2021 | $2,000 | -33.3% | 128 | -16.3% | 0.00% | – |
| Q4 2020 | $3,000 | 0.0% | 153 | -7.8% | 0.00% | – |
| Q3 2020 | $3,000 | +200.0% | 166 | +253.2% | 0.00% | – |
| Q2 2020 | $1,000 | -50.0% | 47 | -63.3% | 0.00% | – |
| Q1 2020 | $2,000 | -98.0% | 128 | -95.7% | 0.00% | -100.0% |
| Q4 2019 | $100,000 | +40.8% | 3,000 | 0.0% | 0.01% | +16.7% |
| Q3 2019 | $71,000 | – | 3,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 789,297 | $39,275,000 | 60.44% |
| Wildcat Capital Management, LLC | 251,459 | $12,513,000 | 9.57% |
| Consonance Capital Management LP | 1,487,491 | $74,018,000 | 4.77% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,499,870 | $124,394,000 | 3.53% |
| MEITAV INVESTMENT HOUSE LTD | 509,355 | $29,967,000 | 1.34% |
| DSAM Partners (London) Ltd | 127,588 | $6,349,000 | 1.28% |
| SHIKIAR ASSET MANAGEMENT INC | 48,125 | $2,395,000 | 1.00% |
| BANK HAPOALIM BM | 67,125 | $3,340,000 | 0.91% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 331,900 | $16,515,000 | 0.55% |
| Clal Insurance Enterprises Holdings Ltd | 310,000 | $15,426,000 | 0.40% |